Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
about
Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.Contribution of bone marrow-derived fibrocytes to liver fibrosisThe pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodellingA serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs.Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo.Serum markers may distinguish biliary atresia from other forms of neonatal cholestasisDiscovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.Inflammatory clearance of apoptotic cells after UVB challenge.Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasmaSystemic lupus erythematosus and familial Mediterranean fever: a possible negative association between the two disease entities--report of four cases and review of the literature.Amniotic fluid pentraxins: Potential early markers for identifying intra-amniotic inflammatory complications in preterm pre-labor rupture of membranes.
P2860
Q27687176-F646469B-D750-4CE7-A169-6C076E7F0F77Q28083363-A6B5E5C5-ABE3-4030-AC82-81CA179AA127Q33632041-C459CD0A-15BC-41C7-9771-2E5956895210Q33772501-3E7DC794-6800-4497-8F00-132539B474E2Q33782308-4B00A073-9492-46BC-BA54-E62EF1CFF48DQ33897486-E88FCFC4-E0DB-4001-B1A8-62D2EADBE23BQ34047987-5B9AD94C-D1EF-4C86-8476-A40E7B623E8DQ35555094-06A5E703-FC3D-4A1E-893B-95D9DA95EDC1Q36827912-A7E627ED-A15B-4046-AF3A-DA0277B48351Q36846090-2D0CC406-F1A9-4BA5-8EB6-DE055A37BFA1Q37215910-2CB7EF78-04E5-4DD8-ADA2-4112B59EDA74Q47343441-4665C6F9-70C5-4201-A5D8-6125E74DDC8B
P2860
Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Serum amyloid P component leve ...... uring an acute phase reaction.
@ast
Serum amyloid P component leve ...... uring an acute phase reaction.
@en
type
label
Serum amyloid P component leve ...... uring an acute phase reaction.
@ast
Serum amyloid P component leve ...... uring an acute phase reaction.
@en
prefLabel
Serum amyloid P component leve ...... uring an acute phase reaction.
@ast
Serum amyloid P component leve ...... uring an acute phase reaction.
@en
P2093
P2860
P356
P1476
Serum amyloid P component leve ...... uring an acute phase reaction.
@en
P2093
Kallenberg CG
Limburg PC
Van Der Geld Y
Van Rijswijk MH
P2860
P304
P356
10.1136/ARD.2002.004796
P407
P577
2004-07-01T00:00:00Z